Anti-angiogenic therapies are being pursued as means of starving tumors of their energy supply.
Introduction
The survival of cancer cells is contingent on their supply of oxygen and nutrients such as glucose via the blood-stream. The establishment and growth of malignant tumors are, therefore, critically dependent on their ability to stimulate the formation of new blood vessels (angiogenesis) to support their metabolic needs (1) . During the past decades, anti-angiogenic therapies have been pursued as a means of inhibiting tumor growth (2) . Such therapeutic oxygen deprivation might be expected to have unwanted side-effects if unsuccessful: cancer cells become more aggressive, more resistant to chemo-and radiation-therapy, and more likely to metastasize under hypoxic conditions (3) . Surprisingly, anti-angiogenic drugs have since been proven to have modest effect on tumor growth when administered alone (4, 5) , but to be efficacious in combination with both chemotherapy and irradiation (6, 7) -even beyond an additive effect of the combined treatments (8) . This has led to the hypothesis that anti-angiogenic drugs prune the chaotic tumor microvasculature to provide a more even distribution of blood and anti-cancer drugs across tumors, thereby improving tissue oxygenation and drug-responses (9) . In support of this notion, experimental studies have demonstrated that anti-angiogenic treatment is followed by a 'vascular normalization window', during which microvascular density, length, diameter, and tortuosity are reduced, capillary pericyte coverage is increased, and the basement membrane thickness and capillary permeability to plasmaproteins normalized (7, 10) . In some studies, these changes are paralleled by increased tumor oxygenation and sensitivity to radiation and cytotoxic therapy are significantly increased (7, 10) . This is not a consistent finding, however, in that as many studies have shown angiogenesis inhibitors to reduce tumor oxygenation (8, 11) .
The finding that reductions in tumor microvascular density can improve tumor oxygenation and the delivery of small molecules to tumor tissue contradicts not only the original rationale for antiangiogenic therapy, but also appears to contradict fundamental principles of physiology and pharmacokinetics. According to these, the extraction of diffusible molecules, including oxygen and pharmaceuticals, always decrease if capillary surface area is reduced for a given tumor blood flow.
The cause of this paradox must therefore lie in profound, therapy-related changes in either tumor blood supply, or in the extraction of solutes by the tumors.
The blood flow and oxygenation is well-characterized in several tumor types (12) (13) (14) (15) . Most tumors display considerable variability in tumor blood flow (TBF, mL blood/mL tissue/minute), both within and among tumors of a given type, with TBF ranging from near-zero to several times that of the surrounding, normal tissue (12, 16) . The oxygen extraction fraction (OEF) in tumor tissue is generally poor, ranging from only 5% to 50% of the incoming arterial blood's total oxygen content (12) . Most often, blood flow and low oxygen extraction combine to a low availability of oxygen in tumors, as evidenced by oxygen tensions that are generally lower than those of surrounding tissue (12) (13) (14) (15) (16) . The incomplete extraction of oxygen by tumors with low tissue oxygen tension is characterized as diffusion-limited or chronic hypoxia to indicate that oxygen diffusion from blood tissue must somehow be hindered (16) . In some tumors, blood is constantly redistributed across tumor parts ('cycling'), resulting in what has been dubbed flow limited or acute hypoxia (16).
Chronic hypoxia is traditionally ascribed to increased diffusion distances from capillaries to cells within the chaotic tumor microvasculature, causing cells far from capillaries to receive less oxygen than required (16) . This notion is difficult to reconcile with the finding that tumor oxygenation in many cases improves as a result of anti-angiogenic treatment, during which average inter-capillary distances invariably increase. A more recent hypothesis of chronic tumor hypoxia states that the microvasculature tends to develop functional arteriovenous shunts in the absence of the normal signaling of metabolic needs among microvessels (17) . If vascular normalization restored normal signaling, such shunting might be reduced, the distribution of blood across the microvasculature improved, and oxygen extraction thereby increased (18) . We recently developed a model of the extraction of oxygen and other freely diffusible substances in tissue. The model extends the traditional flow-diffusion equation (19) to take not only blood flow into account, but also the effective shunting that occurs as some blood flows along capillary paths with limited oxygen extraction (20) . In this review, we briefly describe the model and then examine its prediction with regards to the net extraction of oxygen, glucose and cytotoxic molecules under the assumption that tumor angiogenesis is accompanied by increased capillary transit time The relation TBF and the amount of freely diffusible molecules that can be extracted by tumor tissue is derived from the so-called flow-diffusion equation (19) . The equation accurately describes the extraction of freely diffusible substances from a single capillary perfused at a given blood velocity. Replacing capillary flow velocity by tissue blood flow, this equation is now widely used to model the net extraction of freely diffusible substance in tissue, given the net capillary surface area per unit tissue volume, and their permeability to the substance (19) . Figure 2B by anti-angiogenic therapy is inherently difficult to predict. Below, we describe a general framework for estimating tumor oxygenation based on capillary transit time patterns such as those shown in Figure 2C , and demonstrate how treatment-related changes in capillary transit time patterns can be utilized to predict parallel changes in the net oxygenation of individual tumors, cf. Figure 2D .
An extended flow-diffusion equation
We recently extended the flow-diffusion equation to take the effects of CTH into account. The model is described in detail elsewhere (20) The tumor's microcirculation is highly chaotic, owing to the aberrant topology, morphology and patency of newly formed microvessels, the increased vascular permeability and pressure from surrounding fluids and tissue cells, and altered blood rheology (12) . Tumor angiogenesis is therefore expected to increase CTH as shown by the insert in Figure 1 , and indicated by the arrows in Figure 3A . As indicated by the vertical components of the arrows in Figure 3A , an increase in CTH caused by angiogenesis can result in a significant reduction in OEF max for a given TBF and (12) . Also note that TBF is predicted to be a poor predictor of tumor oxygenation without simultaneous knowledge of CTH. By definition, angiogenesis increases the capillary blood volume. Meanwhile, the tumor expands, and the net capillary blood volume per unit tumor volume may therefore either increase, decrease, or remain constant. Note, however, that unless TBF increases in proportion to CBV, then MTT (equal to CBV/TBF), increases. The two cases of either reduced or prolonged MTT are indicated by the horizontal components of the two arrows in Figure 3A .
The net extraction of diffusible molecules
The upper limit imposed by the tumor's microcirculation on the local metabolic rate of glucose, 
increased flow rate -See the oblique arrow in Figure 3B . Similarly, the model predicts that antiangiogenic treatment can improve tumor oxygenation, and the extraction of cytotoxic molecules, by reducing CTH. While CTH has been shown to decrease in response to one anti-angiogenic agent, cf. Figure 2C , the schematic drawing in Figure 2B illustrates that tumor oxygenation responses are likely to depend critically on the way in which the microvascular 'pruning' affects the shunting of oxygenated blood. As illustrated by Figure 2D , this uncertainty may explain the variability of tumor oxygenation changes after anti-angiogenic therapy (8, 11) , and may suggest measurements of CTH and MTT responses to anti-angiogenic therapy across tumors as means of understanding these oxygenation responses.
Aerobic Glycolysis
The iso-contour plot in Figure 3C . shows the net oxygen:glucose extraction ratio (OGR). where oxygen tension cannot be reduced further. At this time, the tumor effectively outgrows its vasculature, and necrosis is predicted to ensue. Note that MTT increases by a factor of 2 as CTH increases between condition a and b, that is, TBF is reduced by a factor of 2. As CTH increases for a fixed CBV, the metabolic needs of the tumor can therefore be met by reducing TBF to ensure a higher oxygen extraction. This is consistent with the general finding of lower TBF in tumors than in their host tissue (12) . 
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The tendency of the tumor microcirculation to loose normal hemodynamic control has been described and modeled in detail by Pries and colleagues (17, 18) , who also coined the associated 'shunt problem': Poor extraction of oxygen, glucose, and pharmaceuticals in tumors as blood is effectively shunted through capillaries with poorly controlled flow (18) . The extent to which the extraction of diffusible substances is reduced by the loss of normal hemodynamic control across the capillary bed can be addressed by advanced simulation models of the microcirculation (17, 18) . The extended flow-diffusion model (20) , in its current form, does not account for non-uniform substance concentrations and spatial diffusion properties at the microscopic level -See discussion in Ref. (20) . By these simplifications, it permits us to address salient features of the shunt problem for oxygen, glucose, and freely diffusible pharmaceuticals, based on tumor MTT (or blood flow) and CTH. Both these parameters can be derived from the retention of intravascular contrast agents in the tumor vasculature as observed by dynamic magnetic resonance imaging, computerized tomography, or contrast enhanced ultrasound (23, (28) (29) (30) , as exemplified in Figures 1 (insert) and 2C. In principle, these techniques can therefore be applied in human malignancies in relation to therapies that target the tumor microvasculture. In preclinical models, intravital optical imaging techniques (10) provide additional means to achieve this information.
We propose that MTT and CTH estimates may predict the oxygenation status of tumors, their metabolic status in terms of ATP yields from mixed oxidative phosphorylation and glycolysis (27) , and their uptake of freely diffusible molecules. Our analysis of MTT and CTH data obtained in an experimental tumor model shows that CTH can be normalized in part by anti-angiogenic therapy (23) , but further suggests that the change in tumor oxygenation depends on parallel changes in MTT, cf. Figure 2D . While these findings reemphasize the need to understand tumor angiogenesis and hemodynamic control (17, 18) , they also suggest that existing diagnostic imaging techniques Table 1 in Ref. (26) .
We chose xenografted breast carcinoma grown to a size of around 2.5 g (35±1 days) in mice, for which TBF = 16 mL/100 mL/min, TMRO 2 = 1.18 mL/100mL/min, OEF = 0.46. To calibrate the model parameter k for oxygen, we assumed P t O 2 to be 7.5 mmHg, and set CBV to 3 mL/100mL
(corresponding to MTT = 11.25 sec) and CTH to 95% of MTT under these conditions. The arterial blood oxygen concentration was set to 0.185 mL/mL. 
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The green surface in panel 3D corresponds to combinations of MTT, CTH, and P t O 2 , for which oxygen availability precisely matches the TMRO 2 of the xenografted breast carcinoma in panel 3B
(TMRO 2 = 1.18 mL/100mL/min) (26) . The interior of the half-cone therefore represents combinations of MTT, CTH and P t O 2 for which this the metabolic needs of this tumor type can be met. The red plane marks the boundary of malignant CTH, to the left of which increased tumor blood flow would reduce tumor oxygenation. Note that as CTH increases, for example at a tissue P t O 2 of 15 mmHg, tumor oxygen metabolism can no longer be supported as CTH reaches the critical limit indicated by a. The model predicts that as CTH increases further, the metabolic needs of the tumor can only be met provided TBF can be suppressed (MTT prolonged) and P t O 2 reduced.
The resulting decrease in the degree of shunting and improved blood-tissue concentration gradient permit higher levels of CTH, until oxygenation finally becomes critical as P t O 2 approaches zero. 
